Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completed

Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

NCT02106611
completednot_applicable

Dobutamine vs Adenosine CMR Study

NCT03661827
completednot_applicable

Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease

NCT04022395

Clinical Trials (3)

Showing 3 of 3 trials
NCT02106611

Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

Completed
NCT03661827Not Applicable

Dobutamine vs Adenosine CMR Study

Completed
NCT04022395Not Applicable

Stress CMR in Pediatric Patients With Suspected Coronary Artery Disease

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3